A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/445 (2006.01) A61K 31/38 (2006.01) A61K 31/40 (2006.01) A61K 31/4025 (2006.01) A61K 31/4535 (2006.01) A61K 31/55 (2006.01)
Patent
CA 2214080
A method of inhibiting ovarian cancer comprising administering to a human in need thereof an effective amount of a compound having formula (I), wherein R1 and R3 are independently hydrogen, -CH3, (a), or (b), wherein Ar is optionally substituted phenyl; R2 is selected from the group consisting of pyrrolidine, hexamethyleneimido, and piperidino; or a pharmaceutically acceptable salt or solvate thereof.
Méthode d'inhibition du cancer de l'ovaire consistant à administrer au sujet humain concerné une dose efficace d'un composé de formule (I) dans laquelle R?1¿ et R?3¿ sont, indépendamment, de l'hydrogène, -CH¿3?, a) ou b), où Ar est un phényle éventuellement substitué; R¿2? est choisi dans le groupe constitué de pyrrolidine, hexaméthylèneimino et pipéridino; ou son sel ou solvate pharmaceutiquement acceptable.
Eli Lilly And Company
Gowling Lafleur Henderson Llp
LandOfFree
Methods of inhibiting ovarian cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of inhibiting ovarian cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of inhibiting ovarian cancer will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1819983